GSE280813

Licochalcone B alleviates Crohn’s Disease injury by targeting FTO [meRIP-seq]

Whole-study status Not suitable

Dataset does not meet the current suitability threshold.

Whole-study downloads — these do not apply your sample requirements.

Selected cohort requirements

Samples meeting selected requirements: 0 cases / 0 controls

View matching samples

6 case / 6 control samples elsewhere in the study have incomplete or conflicting evidence; they are not included above

Patient pairs verified in indexed sample metadata: 0

A case/control comparison meeting these requirements is not confirmed.

Counts describe samples, not independent patients. Pair verification uses explicit subject identifiers in indexed sample metadata. Zero verified pairs does not establish that the study is unpaired; reported matched-normal design alone is insufficient.

Summary

To investigate the mechanism of demethylase FTO in Crohn's disease,We used m6A MeRIP-seq data from three normal colon samples and three TNBS-induced IBD colon samples of C57 mice for gene expression profiling.

Overall design

Comparative gene expression profiling analysis of m6A MeRIP-seq data from three normal colon samples and three TNBS-induced IBD colon samples of C57 mice

Source Evidence

4 sources
Source Contribution Status
GEO

Original dataset metadata, sample metadata, source links, and GEO data availability flags.

Sample records
12 GSM samples
Primary source
recount3

Planned trusted source for processed count availability.

No match found
Expression Atlas

Planned source for curated expression experiment links.

No match found
PubMed

Publication context when PubMed identifiers are already known.

No match found

Metadata Quality Components

Analysis Readiness

Review before analysis
90% DE readiness

Contrast completeness

25/25 pts

Both case and control groups are present in the proposed grouping.

Minimum group size

20/20 pts

Each contrast group has at least 2 samples.

Processed data availability

20/20 pts

Processed data is marked available in the GEO index.

Sample decision clarity

15/15 pts

All samples are assigned to a case or control group.

Blocking warnings

0/10 pts

Critical warnings must be resolved before downstream analysis.

Metadata normalization

10/10 pts

Metadata quality is high enough to support downstream handoff.

Blockers

  • Critical dataset warnings must be resolved.

Next Steps

  • Resolve critical warnings before downstream analysis.

Analysis Preparation Checklist

5/6 ready

Group labels reviewed

Needs review

Siftome proposed case and control labels, but no reviewer confirmation is stored yet.

Open the sample grouping CSV and confirm group labels before analysis.

Minimum sample count met

Ready

Both groups meet the minimum of 2 samples.

Confirm whether the cohort is large enough for the intended statistical analysis.

Processed counts available

Ready

Processed data availability is marked true in the GEO index.

Verify that downloaded processed files contain usable count or expression identifiers.

Ambiguous samples handled

Ready

No review-needed or unassigned samples are present in the proposed grouping.

Review the grouping table for biologically meaningful differences that the automated checks may not detect.

Exclusion decisions recorded

Ready

No hard-excluded samples were detected by the current rules.

Record any manual exclusions in the downstream analysis notes.

Source traceability preserved

Ready

The dataset and sample accessions can be traced back to GEO.

Keep GEO accessions with exported metadata.

Bioinformatician Review

Bioinformatician review required

Ask a bioinformatician to review grouping, count availability, exclusions, and design before DE.

Analysis readiness has blockers that must be resolved before DE.

Critical dataset warnings are present.

Why This Is Ranked Here

Tumor vs normal
Not suitable Dataset does not meet the current suitability threshold.

Applied Review Decisions

No active review decisions affect this ranking.

Derived Classifications

  • Organism differs from search intent Mus musculus Search intent expects Homo sapiens. Organism came from Normalization rules.
  • Disease context Crohn's disease, inflammatory bowel disease Disease context came from Normalization rules.
  • Likely case group Inflammatory bowel disease 6 samples
  • Likely control group Healthy control 6 samples

Ranking Facts

Supporting evidence

  • Comparison: Disease/model vs control. Specimen: Tissue. Comparison suitability: 0%.
  • Prioritized assay: bulk RNA-seq is the active assay expectation.
  • Interpreted disease metadata: Crohn's disease, Inflammatory bowel disease.
  • Processed data is available for downstream review.

Cautions

  • Disease/control design without a tumor/normal comparison is outside tumor/normal triage.
  • Overall score capped because comparison suitability is weak for the selected search intent.
  • Overall score capped because non-human datasets are outside the selected human ranking intent.
  • Comparison suitability score is below the Phase 1 recommended threshold.

Dataset Warnings

Normalized Fields

41 fields

Sample Group Preview

12 rows shown
Show Hide
Study totals: Case 6 | Control 6 | Unassigned 0 | Excluded 0 | Ambiguous 0 12 rows shown
Group Role Accession Title Source / characteristics Reason
Inflammatory bowel disease Case GSM8606112 Colonic tissue, M-1, input Colon Tissue: Colon; Genotype: WT; Treatment: TNBS-induced IBD Disease-state value stored under a treatment-labelled characteristic detected.
Inflammatory bowel disease Case GSM8606113 Colonic tissue, M-2, input Colon Tissue: Colon; Genotype: WT; Treatment: TNBS-induced IBD Disease-state value stored under a treatment-labelled characteristic detected.
Inflammatory bowel disease Case GSM8606114 Colonic tissue, M-3, input Colon Tissue: Colon; Genotype: WT; Treatment: TNBS-induced IBD Disease-state value stored under a treatment-labelled characteristic detected.
Inflammatory bowel disease Case GSM8606118 Colonic tissue, M-1, IP Colon Tissue: Colon; Genotype: WT; Treatment: TNBS-induced IBD Disease-state value stored under a treatment-labelled characteristic detected.
Inflammatory bowel disease Case GSM8606119 Colonic tissue, M-2, IP Colon Tissue: Colon; Genotype: WT; Treatment: TNBS-induced IBD Disease-state value stored under a treatment-labelled characteristic detected.
Inflammatory bowel disease Case GSM8606120 Colonic tissue, M-3, IP Colon Tissue: Colon; Genotype: WT; Treatment: TNBS-induced IBD Disease-state value stored under a treatment-labelled characteristic detected.
Healthy control Control GSM8606109 Colonic tissue, N-1, input Colon Tissue: Colon; Genotype: WT; Treatment: Normal feeding Explicit characteristic control arm detected.
Healthy control Control GSM8606110 Colonic tissue, N-2, input Colon Tissue: Colon; Genotype: WT; Treatment: Normal feeding Explicit characteristic control arm detected.
Healthy control Control GSM8606111 Colonic tissue, N-3, input Colon Tissue: Colon; Genotype: WT; Treatment: Normal feeding Explicit characteristic control arm detected.
Healthy control Control GSM8606115 Colonic tissue, N-1, IP Colon Tissue: Colon; Genotype: WT; Treatment: Normal feeding Explicit characteristic control arm detected.
Healthy control Control GSM8606116 Colonic tissue, N-2, IP Colon Tissue: Colon; Genotype: WT; Treatment: Normal feeding Explicit characteristic control arm detected.
Healthy control Control GSM8606117 Colonic tissue, N-3, IP Colon Tissue: Colon; Genotype: WT; Treatment: Normal feeding Explicit characteristic control arm detected.

Use as Discovery Cohort

External Validation Finder

Carry Siftome's disease, organism, specimen, assay, data type, and accession into a validation project. Uncertain fields remain Unknown.